CADL
CADL: Loggia Nicoletta discloses securities transactions
Loggia Nicoletta reported Grant or award in Candel Therapeutics, Inc.: 380 units of Stock Option (Right to Buy) (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.